Although CRP and PTX3 belong to the pentraxin family, PTX3 is, in contrast to CRP, produced at the site of vascular inflammation [33], potentially promoting its strength as a prognostic biomarker in certain inflammatory disorders like CAD and its complications [18]. Here, PTX3 is linked to coronary artery disorder.